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Group B streptococcal cells, either viable or heat-killed, 
contain a substance that induced fever in rabbits with 
maximal responses occurring four hours after intravenous 
injection. In contrast, supernatant fluids failed to induce 
significant fever. Group B streptococcal cells also enhanced 
host susceptibility to lethal shock by endotoxin as much as 
40,OOO-fold. A graph of log streptococcal cell dose used for 
pretreatment versus log LD5/) endotoxin gave a straight line 
with a slope of approximately -1. Rabbits that received 
both streptococcal cells and endotoxin showed initial fever 
followed by hypothermia, labored breathing, watery diar-
rhea, evidence of vascular collapse, and finally death. Ani-
mals that received streptococcal cells or endotoxin alone 
showed only fevers and mild diarrhea. A possible theory for 
the cause of death in the neonate infected with group B 
streptococci is presented. (Obstet Gynecol 61:588, 1983) 
During the past 20 years, an early-onset infection 
syndrome associated with group B tJ-hemolytic strep-
tococcus has emerged as a major cause of neonatal 
death. Attack rates as high as three to four per 1000 live 
births and mortality rates as high as 75% have been 
reported. I This early-onset infection syndrome usually 
appears within the first 48 hours of life, but can often 
be seen within the first 12 to 24 hours. As early as the 
1960s, investigators noted a clinical similarity between 
early-onset group B streptococcal infection in the neo-
nate and endotoxin shock in the adult. 2-4 Both may be 
characterized by respiratory distress, hypotension, 
temperature instability, leukopenia or leukocytosis, 
disseminated intravascular coagulation (DIC), oliguria, 
and failure to respond to appropriate antibiotic thera-
py. 
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The possibility of pyrogenic exotoxin production by 
group B streptococci would not be unique among 
gram-positive cocci. Toxins of group A streptococci are 
thought to induce the clinical features of scarlet fever 
and may contribute to development of rheumatic fever 
and glomerulonephritis,5,6 whereas staphylococcal en-
terotoxins produce numerous gastrointestinal symp-
toms. Recently, studies reported by Schlievert et al7 
have suggested that staphylococcal pyrogenic exotox-
ins may be associated with endotoxin to cause toxic 
shock syndrome by enhancing host susceptibility to 
lethal shock. 
Although several groups have reported the isolation 
of potentially pathogenic extracellular products,8.9 pro-
duction of a lethal toxin has not been demonstrated for 
group B streptococci. However, a situation similar to 
the interaction of staphylococcal pyrogenic exotoxin 
and endotoxin that is thought to cause toxic shock 
syndrome could also occur with group B streptococ-
cus. Studies were therefore conducted to determine 
whether a product of group B streptococci could act 
synergistically with endotoxin to produce similar ef-
fects in an animal model. 
Materials and Methods 
Bacterial Isolates 
A clinical isolate of group B tJ-hemolytic streptococcus 
was obtained from a neonate who had succumbed to 
early-onset group B streptococcal infection. The isolate 
was serotype III and was maintained in the lyophilized 
state in the presence of fresh defibrinated rabbit blood. 
Group B streptococci were grown in pyrogen-free 
dialyzable beef-heart medium7 until stationary growth 
phase was achieved. Plate counts were performed to 
estimate the number of bacterial colony forming units 
Obstetrics & Gynecology 
(CFUs) per milliliter; stationary phase concentration 
was found to be 5 x 108 CFU/ml. 
Both live and killed cells were studied. In experi-
ments involving killed cells, the organisms were de-
stroyed by exposure to 65C for 30 minutes. Cell-free 
supernatant fluids were prepared by centrifugation 
and passage through 0.45 J-L filters (Millipore Corpora-
tion, Freehold, NT). 
Animals 
Young adult American Dutch belted rabbits weighing 
1.0 to 1.7 kg were used. The animals were kept in 
quarantine for one week before use. Healthy rabbits 
were conditioned to a restraining device for at least one 
day before use, and indwelling rectal temperature 
probes were inserted one hour prior to use in tests for 
pyrogenic exotoxin. 
Endotoxin 
Endotoxin was derived from Salmonella typhimurium 
by the phenol-water method of Westphal and asso-
ciates. IO It was diluted in phosphate-buffered saline 
(O.OOS M phosphate, 0.15 M NaCl, pH 7.0) for intrave-
nous injection. The LDso of endotoxin was determined 
to be approximately 400 J-Lg/kg by the method of Reed 
and Muench. II 
Staphylococcal Pyrogenic Exotoxin C 
Staphylococcal pyrogenic exotoxin C was prepared 
from strains of Staphylococcus aureus isolated from 
patients with toxic shock syndrome by the isoelectric 
focusing technique of Schlievert et al. 7 Purified toxin 
was administered intravenously in normal saline. 
Group A Streptococcal Cell Walls 
Group A streptococcal strain T253 (T12 gl)12 was cul-
tured overnight in 100 ml beef-heart medium. The cells 
were collected by centrifugation (650 x g, 10 minutes), 
restored to ten ml with phosphate-buffered saline, and 
killed by incubation in a 65C waterbath for 30 minutes. 
After cooling, the killed cells were treated with hyal-
uronidase (10 mg) for one hour at 37C. The cells were 
then centrifuged (650 x g, ten minutes), resuspended 
in phosphate-buffered saline (pH 8.0) containing 1% 
trypsin (Difco Laboratories, Detroit, Mich), and incu-
bated an additional hour at 37C. Finally, the cell wall 
preparation was washed three times with phosphate-
buffered saline (650 x g, ten minutes) and suspended 
in phosphate-buffered saline to an absorbance of 1.50 
at 540 nrn, which corresponded to approximately 2 x 
108 CFU/ml of viable organisms. 
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Pyrogenic Activity of Group B Streptococci 
Group B I3-hemolytic streptococci were grown in dia-
lyzable beef-heart medium, and 1.0 ml/kg of either live 
cells, killed cells, or supernatant fluid was injected into 
test groups of four animals each. Fever responses were 
then monitored hourly. 
To determine whether the pyrogenic response with 
group B streptococci was similar to that seen with 
other pyrogens, healthy rabbits were prepared and 
injected with known pyrogens and febrile responses 
were compared. Endotoxin (1 J-Lg/kg) derived from S 
typhimurium, staphylococcal pyrogenic exotoxin type 
C (3 J-Lglkg) , and cell walls (1 mVkg) derived from 
group A streptococcal strain T253 (T12gl) were each 
injected into four animals per group and the febrile 
responses were determined. 
Endotoxin Enhancement 
To assess the capacity of group B streptococcal cells or 
supernatant fluid to enhance host susceptibility to 
lethal endotoxin shock, groups of four animals were 
initially prepared and treated with either live cells, 
killed cells, or supernatant fluid. Also, six animals 
were pretreated with 1.0 mVkg stationary phase con-
centration of viable pyrogenic exotoxin-negative S aur-
eus cells. Each animal then received 10 J-Lglkg of endo-
toxin via a marginal ear vein four hours after initial 
treatment and was observed for response. 
LDso Determination 
The LDso group B streptococci and endotoxin were 
determined by administering concentrations of killed 
organisms at 0 hours and of endotoxin at 4 hours. LDso 
determinations were made using the technique of 
Reed and Muench. II 
Results 
Healthy rabbits who received 1.0 mVkg of live cells or 
killed cells (5 x 108 CPU/ml) developed the characteris-
tic pyrogenic exotoxin fever response (Figure 1). This 
response was maximal at 4 hours and then returned to 
normaL Minimal pyrogenic response occurred with 
injection of supernatant fluid from the organisms. All 
animals survived without apparent sequelae. 
When compared with the fever response curves of 
endotoxin (S typhimurium), peptidoglycan (group A 
streptococcus), and pyrogenic exotoxin C (S aureus), 
the fever response of the group B streptococcal organ-
isms most closely resembled that of the staphylococcal 
pyrogenic exotoxin C (Figure 2). Again, all animals 
survived without apparent sequelae. 

















Figure 1. Pyrogenicity in rabbits of viable group B streptococcal 
cells (closed circles), heat-killed group B streptococcal cells (open 
circles), and cell-free culture supernatant fluids (squares). Group B 
streptococci cultured in dialyzable beef-heart medium until stationary 
phase growth (5 x loB CFU/ml) achieved. All injections were 
intravenous (1 mllkg) in phosphate-buffered saline; four rabbits per 
group. Average fever responses are shown. 
As Figure 3 shows, all animals that were initially 
treated with the pyrogenic preparations of group B 
streptococci and four hours later received 10 ltg/kg of 
endotoxin died. In contrast, no animals died when 
treated with the nonpyrogenic group B streptococcal 
preparation (supernatant fluid) and challenged four 
hours later with 10 Itglkg of endotoxin. Rabbits that 
received streptococcal cells immediately followed by 
endotoxin developed fevers followed by hypothermia, 
labored breathing, profuse watery diarrhea, evidence 
of vascular collapse, and finally death . 
. When rabbits were injected with live or killed cells or 
supernatant fluid concomitantly with 10 Itglkg of en-
dotoxin, only fever and mild diarrhea occurred, and all 
animals survived. This was also true when the rabbits 
were pretreated with 10 ltg/kg of endotoxin one hour 
before receiving either the cells or supernatant fluid. 
These findings suggest that endotoxin challenge 
causes death only when preceded by treatment with a 
pyrogenic preparation of group B streptococci. 
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By varying the number of killed organisms (given at 
o hours) and the concentration of endotoxin (given at 4 
hours) administered to groups of four rabbits, the LDso 
of each agent alone and in combination was deter-
mined. An inverse correlation between the two was 
found (Table 1). The concentration of endotoxin alone 
required to produce LDso in the rabbits was found to 
be approximately 400 ltg/kg. When the number of 
organisms was increased, the concentration of endotoxin 
required to achieve LDso decreased. When 5 x lOSfrnl 
killed cells were used, the concentration of endotoxin 
required to achieve LDso was 0.1 Itg/kg, or 1/4000 the 
LD50 of endotoxin. The concentration of endotoxin 
needed to produce LDso was 0.01 ltg/kg when viable 
organisms grown to stationary phase (5 x 108) were 
used. This represents an endotoxin enhancement of at 
least 40,000 times. When the log concentration of killed 
cells was plotted against the log LDso of endotoxin, a 
straight line with a slope of 1 resulted (Figure 4). 
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Figure 2. Pyrogenicity of endotoxin (closed circles), 1 J,Lglkglml, 
derived from Salmonella typhimurium, staphylococcal pyrogenic exo-
toxin type C (open circles), 3 J,Lg/kglml, and cell walls from approxi-
mately 2 x 10 CFU/mllkg of group A streptococci (squares). Endotox-
in and group A streptococcal cell walls were administered 
intravenously in phosphate-buffered saline to groups of four rabbits; 
staphylococcal pyrogenic exotoxin was administered intravenously in 
normal saline to groups of four rabbits. Average fever responses are 
shown. 
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B streptococcal cells or cell-free culture superna-
tant fluids. Groups of four animals were pre-
treated for four hours with 5 x lOS CFU/kg/ml viable cells 
of viable or heat-killed cells or 1 mllkg of culture 
fluid. Subsequently, each animal received 10 
/Lg/kg/ml of endotoxin (1150 LOw) derived from killed cells 
Salmonella typhimurium. All injections were in-
travenous; endotoxin was administered in 
phosphate-buffered saline. Deaths were record- supernatant 
ed over a 24-hour period. fluid 
Discussion 
As early as 1966, Maher and Irwin4 noted a clinical 
similarity between the early-onset infection syndrome 
in the neonate and endotoxin shock in the adult. Since 
these two conditions share many clinical features, an 
undefined group B streptococcal toxin may be either 
directly or indirectly responsible for the clinical fea-
tures of the early-onset infection syndrome. 
Pyrogenic exotoxins, which have been defined by 
their capacity to induce fever, also. enhance host sus-
ceptibility to lethal shock by endotoxin.5-7.13-16 Schlie-
vert and associates have presented data7.13 suggesting 
that the combination of staphylococcal pyrogenic exo-
toxin C and host-derived endotoxin may produce 
many features of toxic shock syndrome in rabbits. 
Although preliminary, the present authors' data sug-
gest that a similar mechanism may operate with the 
group B p-hemolytic streptococcal strains employed in 
these experiments. 
For each theory to be plausible, a source of endotox-
in sufficient to produce the symptoms must be demon-
strated. Bacterial colonization of the neonatal intestinal 
tract, including gram-negative bacteria, can occur as 
early as the first day of life. 17 Although dose suscepti-
Table 1. Enhanced Susceptibility of Healthy Rabbits to 
Endotoxin Shock by Group B Streptococci 
Results (dead/total): endotoxin Endo-(peg/kg) given four hours after 
toxin GBS LDlo 
Pretreatment 0.01 0.1 1.0 10.0 100 500 (peg/kg) 
None 0/4 114 214 400 
With killed GBS cells 
1 x 111' 0/3 0/3 213 3/3 58 
1 x 107 0/3 0/3 113 3/3 18 
1 x lOS 0/3 113 113 3/3 
5 x 108 113 113 3/3 3/3 0.1 
With viable cells 
5 x 108 213 3/3 3/3 3/3 0.01 
GBS group B streptococci. 






bility to endotoxin in the human newborn is not 
known, current knowledge suggests that the human is 
more sensitive than the rabbit to the effect of endotox-
in. 12 ,18 Since prior treatment with viable group B 
streptococci decreased by 40,000 times the concentra-
tion of endotoxin required to kill 50% of the rabbits, a 
minimal amount of endotoxin would be required to 
produce an effect in humans. 
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Figure 4. Quantita tive relationship between heat-killed group B 
streptococcal cells and endotoxin in the enhancement of susceptibility 
to lethal shock in rabbits. Rabbits were pretreated with group B 
streptococci four hours before administration of endoto)(in (from 
Salmonella typhimurium). 
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tween the log LDso of endotoxin and the concentration 
of killed group B streptococci further suggests the 
presence of a pyrogenic toxin and is in agreement with 
previous reports of toxins from both group A strepto-
coccis and toxigenic strains of S aureus. 13 
Hellerquist and 'associates8 have recently reported 
the partial characterization of a carbohydrate-protein 
extracellular substance from a strain of group B strep-
tococcus recovered from an infant with early-onset 
infection syndrome. The carbohydrate-protein was 
reported to have a molecular weight of approximately 
200,000 daltons and caused increased pulmonary ar-
tery pressure, decreased P02, chills, and fever, but not 
death, in the sheep. The relationship between this 
carbohydrate-protein and the substance reported here 
is unknown. 
The fact that lethal endotoxin enhancement did not 
occur when nonpyrogenic supernatant fluid was used 
might suggest that the pyrogenic response alone was 
responsible for the observed endotoxin enhancement. 
However, endotoxin challenge following pretreatment 
with either endotoxin or nontoxigenic S aureus failed 
to cause comparable mortality, in spite of a febrile 
response in the rabbit. Therefore, the enhanced sus-
ceptibility to endotoxin shock does not appear to be 
due to the febrile response alone, but to a product of 
the group B streptococci. 
In conclusion, data from the present study suggest 
that a strain of group B I3-hemolytic streptococci isolat-
ed from a newborn with early-onset infection contains 
a substance that increases the susceptibility of the 
rabbit to endotoxin at least 40,OOO-fold. The nature of 
the substance is unknown, but from the febrile re-
sponse it does not appear to be either endotoxin or 
peptidoglycan. Although preliminary, a possible the-
ory for the cause of death in the neonate infected with 
group B streptococci is presented. Further studies to 
elucidate the nature of this substance are currently 
being conducted in the authors' laboratory. 
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